Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony G Marson

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Epilepsia Open|December 11, 2019
Genomic and clinical predictors of lacosamide response in refractory epilepsiesSinéad B Heavin, Mark McCormack, Stefan Wolking, et al.
Neuro-Oncology Practice|August 15, 2025
Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studiesChristopher P Millward, Terri S Armstrong, Sabrina Bell, et al.
Epilepsia|March 7, 2020
Testing association of rare genetic variants with resistance to three common antiseizure medicationsStefan Wolking, Claudia Moreau, Anne T Nies, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Pharmacogenomics|April 21, 2020
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association studyStefan Wolking, Herbert Schulz, Anne T Nies, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic reviewChristopher P Millward, Sumirat M Keshwara, Terri S Armstrong, et al.
Epilepsia Open|August 24, 2019
Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsyKatri Silvennoinen, Nikola de Lange, Sara Zagaglia, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic reviewChristopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Epilepsia Open|December 11, 2019
Genomic and clinical predictors of lacosamide response in refractory epilepsiesSinéad B Heavin, Mark McCormack, Stefan Wolking, et al.
Neuro-Oncology Practice|August 15, 2025
Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studiesChristopher P Millward, Terri S Armstrong, Sabrina Bell, et al.
Epilepsia|March 7, 2020
Testing association of rare genetic variants with resistance to three common antiseizure medicationsStefan Wolking, Claudia Moreau, Anne T Nies, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Pharmacogenomics|April 21, 2020
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association studyStefan Wolking, Herbert Schulz, Anne T Nies, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic reviewChristopher P Millward, Sumirat M Keshwara, Terri S Armstrong, et al.
Epilepsia Open|August 24, 2019
Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsyKatri Silvennoinen, Nikola de Lange, Sara Zagaglia, et al.
Neuro-Oncology Advances|April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic reviewChristopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Pageof 25